Does overexpression of RhoE have a prognostic value in non-small cell lung cancer?
RhoE expression may serve as an unfavorable prognostic factor in patients with non-small cell lung cancer.
Targeting glutaminolysis may represent a potential therapeutic strategy for the treatment of Gln-dependent lung squamous cell carcinomas.